J Korean Assoc Maxillofac Plast Reconstr Surg.  2007 Mar;29(2):187-191.

Ameloblastoma removed by curettage and enucleation after SSRO: case report

• Kil YK
• Kim JC
• Hong YJ
• Oh HS
• Choi B
• Kim KS

Abstract

An ameloblastoma is one of the most common odontogenic tumors. Ameloblastoma is cytologically a benign tumor, but is clinically characterized by infiltrative growth and high recurrency. The treatment of ameloblastoma has been controversial. The aim of this paper is to consider effectiveness of curettage and enucleation after SSRO in the small-sized multilocular intraosseous ameloblastomas that have been treated more frequently by radical treatment. They were radiographically characterized by the cortical bone that was expanded or eroded locally and histopathologically by solid multilocular ameloblastomas. It is considered that curettage and enucleation after SSRO and long-term follow-up enable the small-sized multilocular intraosseous ameloblastomas that were characterized by almost destroyed cancellous bone and expanded cortical bone to treat minimizing facial disfigurement and masticatory dysfunction and sociopsychological impact produced by radical treatment. We recommend that the small-sized multilocular intraosseous ameloblastomas without involvement to the surrounding soft tissues be first treated by curettage and enucleation after SSRO.

Keyword

Curettage and enucleation; Recurrence rate; Small-sized multilocular intraosseous ameloblastomas

MeSH Terms

Ameloblastoma*
Curettage*
Cytochrome P-450 CYP1A1
Follow-Up Studies
Odontogenic Tumors
Cytochrome P-450 CYP1A1